74 related articles for article (PubMed ID: 2443739)
21. High-linear energy transfer (LET) alpha versus low-LET beta emitters in radioimmunotherapy of solid tumors: therapeutic efficacy and dose-limiting toxicity of 213Bi- versus 90Y-labeled CO17-1A Fab' fragments in a human colonic cancer model.
Behr TM; Béhé M; Stabin MG; Wehrmann E; Apostolidis C; Molinet R; Strutz F; Fayyazi A; Wieland E; Gratz S; Koch L; Goldenberg DM; Becker W
Cancer Res; 1999 Jun; 59(11):2635-43. PubMed ID: 10363986
[TBL] [Abstract][Full Text] [Related]
22. The new Tie-1 monoclonal antibodies detect angiogenesis in metastatic malignancies.
Karnani P; Kairemo K
Clin Cancer Res; 2003 Sep; 9(10 Pt 2):3827S-30S. PubMed ID: 14506179
[TBL] [Abstract][Full Text] [Related]
23. Potentiation by interleukin 2 of Burkitt's lymphoma therapy with anti-pan B (anti-CD19) monoclonal antibodies in a mouse xenotransplantation model.
Vuist WM; v Buitenen F; de Rie MA; Hekman A; Rümke P; Melief CJ
Cancer Res; 1989 Jul; 49(14):3783-8. PubMed ID: 2472198
[TBL] [Abstract][Full Text] [Related]
24. Rapid blood clearance of injected mouse IgG2a in SCID mice.
Michel RB; Ochakovskaya R; Mattes MJ
Cancer Immunol Immunother; 2002 Nov; 51(10):547-56. PubMed ID: 12384806
[TBL] [Abstract][Full Text] [Related]
25. Galactose-conjugated antibodies in cancer therapy: properties and principles of action.
Ong GL; Ettenson D; Sharkey RM; Marks A; Baumal R; Goldenberg DM; Mattes MJ
Cancer Res; 1991 Mar; 51(6):1619-26. PubMed ID: 1998953
[TBL] [Abstract][Full Text] [Related]
26. Effects of radiolabeling monoclonal antibodies with a residualizing iodine radiolabel on the accretion of radioisotope in tumors.
Stein R; Goldenberg DM; Thorpe SR; Basu A; Mattes MJ
Cancer Res; 1995 Jul; 55(14):3132-9. PubMed ID: 7606734
[TBL] [Abstract][Full Text] [Related]
27. [Monoclonal anti-idiotype antibodies in immunotherapy of ovarian carcinoma (MAb ACA125) and breast carcinoma (MAb ACA14C5)].
Wagner U; Köhler S; Prietl G; Giffels P; Schmidt-Nicolai S; Schlebusch H; Grünn U; Bender H; Biersack HJ; De Potter C; Krebs D; Wallwiener D
Zentralbl Gynakol; 1999; 121(4):190-5. PubMed ID: 10355096
[TBL] [Abstract][Full Text] [Related]
28. Human heterophilic antibodies display specificity for murine IgG subclasses.
Bjerner J; Olsen KH; Børmer OP; Nustad K
Clin Biochem; 2005 May; 38(5):465-72. PubMed ID: 15820778
[TBL] [Abstract][Full Text] [Related]
29. Localization of the monoclonal antibody HMFG2 after intravenous and intraperitoneal injection into nude mice bearing subcutaneous and intraperitoneal human ovarian cancer xenografts.
Ward BG; Wallace K
Cancer Res; 1987 Sep; 47(17):4714-8. PubMed ID: 3621167
[TBL] [Abstract][Full Text] [Related]
30. Mouse monoclonal antibodies to human epithelial differentiation antigens expressed on the surface of ovarian carcinoma ascites cells.
Mattes MJ; Look K; Furukawa K; Pierce VK; Old LJ; Lewis JL; Lloyd KO
Cancer Res; 1987 Dec; 47(24 Pt 1):6741-50. PubMed ID: 3677104
[TBL] [Abstract][Full Text] [Related]
31. [The study of immunotherapy of ovarian carcinoma with anti-idiotypic antibody].
Wang J; Qian H; Feng J
Zhonghua Fu Chan Ke Za Zhi; 1996 Jun; 31(6):353-6. PubMed ID: 9206171
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of the in vivo biodistribution of indium-111 and yttrium-88 labeled dendrimer-1B4M-DTPA and its conjugation with anti-Tac monoclonal antibody.
Kobayashi H; Wu C; Kim MK; Paik CH; Carrasquillo JA; Brechbiel MW
Bioconjug Chem; 1999; 10(1):103-11. PubMed ID: 9893971
[TBL] [Abstract][Full Text] [Related]
33. Locoregional alpha-radioimmunotherapy of intraperitoneal tumor cell dissemination using a tumor-specific monoclonal antibody.
Huber R; Seidl C; Schmid E; Seidenschwang S; Becker KF; Schuhmacher C; Apostolidis C; Nikula T; Kremmer E; Schwaiger M; Senekowitsch-Schmidtke R
Clin Cancer Res; 2003 Sep; 9(10 Pt 2):3922S-8S. PubMed ID: 14506190
[TBL] [Abstract][Full Text] [Related]
34. Radioimmunotherapy targeting of HER2/neu oncoprotein on ovarian tumor using lead-212-DOTA-AE1.
Horak E; Hartmann F; Garmestani K; Wu C; Brechbiel M; Gansow OA; Landolfi NF; Waldmann TA
J Nucl Med; 1997 Dec; 38(12):1944-50. PubMed ID: 9430475
[TBL] [Abstract][Full Text] [Related]
35. Movement of IgM antibody from blood to bile in rats.
Hansen PG; Jackson GD
Hepatology; 1991 Sep; 14(3):518-22. PubMed ID: 1714874
[TBL] [Abstract][Full Text] [Related]
36. Prolonged clearance of intraperitoneal 16 alpha-[125I]iodo-17 beta-estradiol in presence of ascites.
Scharl A; Kullander S; Beckmann MW; Spicer JA; Baranczuk RJ; Holt JA
Am J Obstet Gynecol; 1991 Dec; 165(6 Pt 1):1847-53. PubMed ID: 1750485
[TBL] [Abstract][Full Text] [Related]
37. Tissue-level transport mechanisms of intraperitoneally-administered monoclonal antibodies.
Flessner MF; Dedrick RL
J Control Release; 1998 Apr; 53(1-3):69-75. PubMed ID: 9741914
[TBL] [Abstract][Full Text] [Related]
38. Inhibitory effects of alpha 1-antitrypsin derived asialooligosaccharides on the liver uptake of the asialoglycoprotein.
Gan JC
Int J Biochem; 1980; 11(6):481-6. PubMed ID: 6966588
[No Abstract] [Full Text] [Related]
39. The intraperitoneal delivery of radiolabeled monoclonal antibodies: studies on the regional delivery advantage.
Wahl RL; Barrett J; Geatti O; Liebert M; Wilson BS; Fisher S; Wagner JG
Cancer Immunol Immunother; 1988; 26(3):187-201. PubMed ID: 3383203
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of therapeutic efficacy of
Palm S; Bäck T; Aneheim E; Hallqvist A; Hultborn R; Jacobsson L; Jensen H; Lindegren S; Albertsson P
Transl Oncol; 2021 Jan; 14(1):100873. PubMed ID: 32987283
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
